当审判结束时:临床迷幻研究中审判后条款的案例
Edward Jacobs1,2, Ashleigh Murphy-Beiner3,4, Ian Rouiller5
1Department of Psychiatry, University of Oxford, Oxford, UK.
Neuroethics
|November 9, 2023
概括
在临床试验中,试验后获取精神药物 (PTA) 从道德上来说是复杂的. 独特的试验方面支持PTA,但更广泛的试验后护理也对患者的福祉和未来的迷幻医学至关重要.
科学领域:
- 临床心理学 临床心理学
- 心理药理学 心理药理学
- 生物伦理学生物伦理学
背景情况:
- 在研究伦理学中,研究药物试验后获取 (PTA) 的伦理考虑被讨论.
- 迷幻药物临床试验呈现出独特的因素,需要特别注意PTA.
- 没有关于PTA的普遍共识,但它的适当性因试验背景而异.
研究的目的:
- 检查在临床试验中为精神药物提供试验后访问 (PTA) 的伦理考虑.
- 为了确定支持PTA的案例的迷幻试验的非典型方面.
- 倡导一个更广泛的审判后护理概念,而不仅仅是药物获取.
主要方法:
- 文献综述和现有关于审判后访问的研究的伦理分析.
- 检查心理临床试验的具体特征,包括法律地位,治疗关系和治疗持续时间.
- 探索有助于迷幻疗法的疗效的非药理学因素.
主要成果:
- 迷幻试验的独特性质 - - 包括法律地位,治疗师与参与者的关系,以及扩展的治疗过程 - - 支持PTA的伦理考虑.
- 心理辅助心理治疗的有效性受到非药物因素和治疗环境的影响.
- 在迷幻药试验中实施PTA面临着由于资源需求和官僚主义的实际挑战.
结论:
- 迷幻药物研究中的审判后访问 (PTA) 需要因治疗的性质而定制的伦理框架.
- 建议采取更广泛的治疗方法,包括不仅仅是药物获取.
- 将审判后的规定纳入研究过程和资金是为未来的迷幻药物生态系统开发基础设施的必要条件.
更多相关视频
07:30HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice
Published on: July 9, 2016
7.3K
09:29Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
2.2K
相关概念视频
CNS Stimulants: Psychedelic Agents
158
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
158
Ethics in Research
23.0K
Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
23.0K
Hallucinogens and Psychedelics
179
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
179
The Placebo Effect
6.2K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.2K
Altered States of Awareness
208
Altered states of consciousness represent significant deviations from one's normal mental state. These deviations can range from subtle changes in awareness to profound transformations in perception, thought processes, and sensory experiences. Altered states of consciousness can be triggered by various factors, including drug use, meditation, hypnosis, illness, or even intense fatigue.
The ingestion of substances like stimulants or hallucinogens leads to chemical alterations in the brain...
The ingestion of substances like stimulants or hallucinogens leads to chemical alterations in the brain...
208
Blinding
2.5K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.5K
